Ariel Frajerman

6PUBLICATIONS
24CO-AUTHORS
Medical biochemistry - lipidsCancer therapy (excl. chemotherapy and radiation therapy)Learning, motivation and emotionPharmacogenomicsAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 29, 2026
Clozapine-induced neutropenia: Prevalence and associated factors.

|Nov 19, 2025
Metabolomic biomarkers of psychotic conversion in ultra-high-risk subjects: a pilot study.

Maria Teresa Avella, Gildas Bertho, Nicolas Giraud

|Jun 24, 2024
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics.

Xenia Marlene Hart, Gerhard Gründer, Nicolas Ansermot

|Jul 11, 2023
Membrane Lipids in Ultra-High-Risk Patients: Potential Predictive Biomarkers of Conversion to Psychosis.

Ariel Frajerman, Boris Chaumette, Dominique Farabos

|Jul 02, 2021
Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?

Ariel Frajerman, Linda Scoriels, Oussama Kebir

Pageof 1